CUFinder

Kathryn Stephenson

Kathryn Stephenson

Harvard University

H-index: 34

North America-United States

Contact Kathryn Stephenson

About Kathryn Stephenson

Kathryn Stephenson, With an exceptional h-index of 34 and a recent h-index of 29 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Emerging Infectious Diseases, HIV, Zika, Vaccines, Therapeutics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV

Modeling resistance to the broadly neutralizing antibody PGT121 in people living with HIV-1

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission during the Omicron Era in Massachusetts: A Prospective, Case-Ascertained Study using Genomic …

Potent zika virus-specific and cross-neutralizing monoclonal antibodies to zika and dengue viruses following ZIKV infection or vaccination

Rapid development of an integrated network infrastructure to conduct phase 3 COVID-19 vaccine trials

Current Challenges and Solutions for Clinical Management and Care of People with HIV: Findings from the 12th Annual International HIV and Aging Workshop

Risk of COVID-19 after natural infection or vaccination

Clinical and demographic factors associated with COVID-19, severe COVID-19, and SARS-CoV-2 infection in adults: a secondary cross-protocol analysis of 4 randomized clinical trials

Kathryn Stephenson Information

University

Position

Beth Israel Deaconess Medical Center, Harvard Medical School

Citations(all)

6763

Citations(since 2020)

5160

Cited By

3039

hIndex(all)

34

hIndex(since 2020)

29

i10Index(all)

50

i10Index(since 2020)

44

Email

University Profile Page

Google Scholar

Kathryn Stephenson Skills & Research Interests

Emerging Infectious Diseases

HIV

Zika

Vaccines

Therapeutics

Top articles of Kathryn Stephenson

Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV

Pharmaceutics

2024/4/27

Nicole Yates
Nicole Yates

H-Index: 23

Kenneth Mayer
Kenneth Mayer

H-Index: 15

Kathryn Stephenson
Kathryn Stephenson

H-Index: 20

Colleen F Kelley
Colleen F Kelley

H-Index: 25

Lucio Gama
Lucio Gama

H-Index: 25

Modeling resistance to the broadly neutralizing antibody PGT121 in people living with HIV-1

PLOS Computational Biology

2024/3/29

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission during the Omicron Era in Massachusetts: A Prospective, Case-Ascertained Study using Genomic …

Clinical Infectious Diseases

2022/2/1

Susan Hopkins
Susan Hopkins

H-Index: 8

John Bell
John Bell

H-Index: 55

Potent zika virus-specific and cross-neutralizing monoclonal antibodies to zika and dengue viruses following ZIKV infection or vaccination

2024/1/30

Rapid development of an integrated network infrastructure to conduct phase 3 COVID-19 vaccine trials

JAMA network open

2023/1/3

Karen Kotloff
Karen Kotloff

H-Index: 49

Nadine Rouphael
Nadine Rouphael

H-Index: 28

Yuanyuan Zhang
Yuanyuan Zhang

H-Index: 12

Peter Gilbert
Peter Gilbert

H-Index: 12

Lilly Immergluck
Lilly Immergluck

H-Index: 10

Jorge Pinto
Jorge Pinto

H-Index: 11

Kathryn Stephenson
Kathryn Stephenson

H-Index: 20

Stephen Walsh
Stephen Walsh

H-Index: 8

Linda-Gail Bekker
Linda-Gail Bekker

H-Index: 66

Graeme Meintjes
Graeme Meintjes

H-Index: 58

David Bernstein
David Bernstein

H-Index: 14

Dima Dandachi
Dima Dandachi

H-Index: 9

Evan Anderson
Evan Anderson

H-Index: 37

Richard Rupp
Richard Rupp

H-Index: 8

Jorge Sanchez
Jorge Sanchez

H-Index: 3

Steve Shoptaw
Steve Shoptaw

H-Index: 41

Walter Jaoko
Walter Jaoko

H-Index: 29

Mark Mulligan
Mark Mulligan

H-Index: 32

Mary Olson
Mary Olson

H-Index: 8

Current Challenges and Solutions for Clinical Management and Care of People with HIV: Findings from the 12th Annual International HIV and Aging Workshop

AIDS research and human retroviruses

2023/1/1

Risk of COVID-19 after natural infection or vaccination

EBioMedicine

2023/10/1

Ying Huang
Ying Huang

H-Index: 10

Eric Miller
Eric Miller

H-Index: 25

Jayasree Krishnankutty
Jayasree Krishnankutty

H-Index: 3

Amber Grant
Amber Grant

H-Index: 2

Allison Green
Allison Green

H-Index: 1

Anthony Kim
Anthony Kim

H-Index: 32

Michael Desjardins
Michael Desjardins

H-Index: 6

Jennifer A Johnson
Jennifer A Johnson

H-Index: 11

Thomas Weiss
Thomas Weiss

H-Index: 30

Carrie Johnston
Carrie Johnston

H-Index: 2

Nadine Rouphael
Nadine Rouphael

H-Index: 28

Satoshi Kamidani
Satoshi Kamidani

H-Index: 6

Gary Simon
Gary Simon

H-Index: 19

Clinical and demographic factors associated with COVID-19, severe COVID-19, and SARS-CoV-2 infection in adults: a secondary cross-protocol analysis of 4 randomized clinical trials

JAMA network open

2023/7/3

Jacqueline Miller
Jacqueline Miller

H-Index: 16

Eric Miller
Eric Miller

H-Index: 25

Jayasree Krishnankutty
Jayasree Krishnankutty

H-Index: 3

Amber Grant
Amber Grant

H-Index: 2

Allison Green
Allison Green

H-Index: 1

Anthony Kim
Anthony Kim

H-Index: 32

Michael Desjardins
Michael Desjardins

H-Index: 6

Jennifer A Johnson
Jennifer A Johnson

H-Index: 11

Thomas Weiss
Thomas Weiss

H-Index: 30

Carrie Johnston
Carrie Johnston

H-Index: 2

Nadine Rouphael
Nadine Rouphael

H-Index: 28

Satoshi Kamidani
Satoshi Kamidani

H-Index: 6

Gary Simon
Gary Simon

H-Index: 19

Live-attenuated Chikungunya vaccine: a possible new era

The Lancet

2023/6/24

Author Correction: Chikungunya fever

2023/5/19

Safety and immunogenicity of Ad26-vectored HIV vaccine with mosaic immunogens and a novel mosaic envelope protein in HIV-uninfected adults: a phase 1/2a study

The Journal of Infectious Diseases

2023/4/15

Chikungunya fever

2023/4/6

Fatal post COVID mRNA-vaccine associated cerebral ischemia

The Neurohospitalist

2023/4

Kathryn Stephenson
Kathryn Stephenson

H-Index: 20

Efficacy of Messenger RNA–1273 Against Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition in Young Adults From March to December 2021

Open Forum Infectious Diseases

2023/11

Helen Y Chu
Helen Y Chu

H-Index: 29

Molly Rosenberg
Molly Rosenberg

H-Index: 15

Activation of coagulation and proinflammatory pathways in thrombosis with thrombocytopenia syndrome and following COVID-19 vaccination

Nature Communications

2023/10/23

Safety, tolerability, pharmacokinetics, and immunological activity of dual-combinations and triple-combinations of anti-HIV monoclonal antibodies PGT121, PGDM1400, 10-1074, and …

The Lancet HIV

2023/10/1

Kenneth Mayer
Kenneth Mayer

H-Index: 15

Kathryn Stephenson
Kathryn Stephenson

H-Index: 20

Lucio Gama
Lucio Gama

H-Index: 25

Novel chikungunya vaccine shows promise for durable protection

The Lancet Infectious Diseases

2022/9/1

Viral kinetics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron infection in mRNA-vaccinated individuals treated and not treated with Nirmatrelvir-Ritonavir

medRxiv

2022/8/4

Michael Springer
Michael Springer

H-Index: 20

First-in-human evaluation of safety and pharmacokinetics of intravenous or subcutaneous infusions of PGT121. 141. LS, an anti-V3 HIV-1 broadly neutralizing antibody in healthy …

2022/8/1

Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial

Nature medicine

2022/6

Stephen Walsh
Stephen Walsh

H-Index: 8

Lucio Gama
Lucio Gama

H-Index: 25

See List of Professors in Kathryn Stephenson University(Harvard University)